|
|
|
|
LEADER |
01424nam a2200289 u 4500 |
001 |
EB001888777 |
003 |
EBX01000000000000001052138 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200106 r ||| eng |
020 |
|
|
|a 9781473131071
|
245 |
0 |
0 |
|a Renal replacement therapy and conservative management
|h Elektronische Ressource
|c National Guideline Centre (UK)
|
260 |
|
|
|a London
|b National Institute for Health and Care Excellence (UK)
|c 2018, 2018 Oct
|
300 |
|
|
|a 1 online resource
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a United Kingdom
|
653 |
|
|
|a Patient Care Management
|
653 |
|
|
|a Renal Replacement Therapy
|
653 |
|
|
|a Kidney Failure, Chronic / therapy
|
710 |
2 |
|
|a National Guideline Centre (Great Britain)
|
710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a NICE guideline
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK542264
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This guideline covers renal replacement therapy (dialysis and transplantation) and conservative management for people with chronic kidney disease stages 4 and 5. It aims to improve quality of life by making recommendations on planning, starting and switching treatments, and coordinating care
|